The global market for Alzheimer’s treatments is projected to expand significantly, growing from approximately USD 4.82 billion in 2023 to over USD 8.18 billion by 2032. This growth reflects a robust compound annual growth rate (CAGR) of 8.7% during the forecast period from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5130
Cholinesterase inhibitors led the Alzheimer’s treatment market in 2023, accounting for 50% of sales.
Combination drugs are expected to grow the fastest, with an estimated 6.2% annual growth rate through 2032.
Hospital pharmacies were the primary source of Alzheimer’s treatments in 2023.
Alzheimer’s disease is a devastating condition that affects memory, thinking, and daily living. It happens because brain cells die due to changes in the brain. People with Alzheimer’s may struggle with remembering, communicating, and even taking care of themselves.
The exact cause of Alzheimer’s isn’t completely understood, but experts believe it’s due to a mix of genetics, environment, and lifestyle. Aging is the biggest risk factor, but younger people can also get it. Women are more likely to develop Alzheimer’s because they tend to live longer than men.
In 2021, around 6.2 million Americans aged 65 and older had Alzheimer’s. This number could double to nearly 13.8 million by 2060 if new treatments to stop or slow the disease aren’t developed. Alzheimer’s has become one of the leading causes of death among neurodegenerative diseases and often leaves people physically disabled, making timely treatment essential.
While there’s no cure for Alzheimer’s yet, treatments can help manage symptoms and slow its progression. These include medications that boost memory and therapies that support communication and daily tasks. Early diagnosis is critical to helping people with Alzheimer’s maintain independence and quality of life for as long as possible.
Caring for someone with Alzheimer’s can be challenging. It’s essential to create a safe, supportive environment and provide emotional and practical help for caregivers. Effective management of Alzheimer’s can improve life for both patients and their families, ensuring they have the resources and support they need.
In 2021, Amneal expanded its capabilities by acquiring Kashiv Specialty Pharmaceuticals, gaining access to a portfolio of complex generic and branded medicines.
In March 2022, Biogen and Eisai strengthened their collaboration to advance treatments for Alzheimer’s disease.
In October 2022, Cyclo Therapeutics began its Phase 2b study of Trappsol Cyclo, a potential treatment for Alzheimer’s designed to target amyloid beta and tau proteins. The study received approval from the Institutional Review Board (IRB).
In September 2022, Eisai and Biogen shared promising results from the Phase 3 Clarity AD trial of lecanemab. This investigational antibody showed potential for treating mild cognitive impairment and early-stage Alzheimer’s linked to amyloid beta.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/alzheimers-therapeutics-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5130
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the pharmaceutical and biotechnology industries by providing essential services… Read More
The global medical rehabilitation services market has been experiencing significant expansion, driven by various factors such as an aging population,… Read More
The global antibody drug market is experiencing rapid growth, with a notable surge in monoclonal antibody (mAb) demand. The market… Read More
Stroke rehabilitation plays a crucial role in helping individuals regain independence and improve their quality of life following a stroke.… Read More
Healthcare is a multifaceted domain, catering to various needs and conditions. The concept of ambulatory wellness services, which focus on… Read More
Artificial Intelligence (AI) and Machine Learning (ML) have rapidly evolved from emerging technologies to integral components in a variety of… Read More